Overview
Fresenius Kabi Polska specializes in lifesaving medicines and technologies for critically and chronically ill patients across biopharma, medtech, nutrition and pharma. The company also develops blood donation systems with MDR Class III CE certification and supports care for patients throughout the breast cancer journey.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-11-30. Active
19 1880 0009 0000 0011 0102 5041- 32 1880 0009 0000 0011 0102 5001
- 41 1880 0009 0000 0011 0102 5033
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $867.7K$867,654 |
Buildings and premises | $22.3M$22,327,474 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jul 22, 2026 | Return of additional payments | |
| Feb 28, 2014 | Merger plan | |
| May 6, 2013 | Merger plan |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 12, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $13,949$13,949 | Zarządca Rozliczeń S.A. | |
| Aug 12, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $12,059$12,059 | Zarządca Rozliczeń S.A. |
Tenders
2262 tenders recorded as contractor: 476 national ($20,948,968) and 1786 EU ($4,682,000,410).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 15, 2026 | Dostawa leków dla Szpitala Wojewódzkiego im.dr. Ludwika Rydygiera w Suwałkach | –– | Szpital Wojewódzki Im. Dr. Ludwika Rydygiera w Suwałkach | |
| Oct 15, 2026 | 31/26 – Dostawa produktów leczniczych | –– | Szpital Wojewódzki w Bielsku-Białej | |
| Oct 15, 2026 | Dostawa leków dla Szpitala Wojewódzkiego im.dr. Ludwika Rydygiera w Suwałkach | –– | Szpital Wojewódzki Im. Dr. Ludwika Rydygiera w Suwałkach |
Public sector contracts
Fresenius Kabi Polska is the contractor in 690 public sector contracts, worth PLN 140.49m in total. They were signed with 135 public buyers. The largest number (2) were signed with Szpital Uniwersytecki Nr 1 Im. Dr. A. Jurasza w Bydgoszczy.
| Public buyer | Value | |
|---|---|---|
| Uniwersytecki Szpital Kliniczny w Białymstoku | PLN 19.60 | |
| Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego | PLN 812.78 | |
| Wojewódzki Szpital Specjalistyczny Im. Św. Rafała w Czerwonej Górze | PLN 2,080 | |
| Szpital Wojewódzki Im. Kardynała Stefana Wyszyńskiego w Łomży | PLN 403.60 | |
| Uniwersytecki Szpital Dziecięcy w Krakowie | PLN 1,104 |
Public procurement disputes (KIO)
Fresenius Kabi Polska has been a party to 20 cases before the National Appeal Chamber (since 2018). It filed 14 appeals (2 upheld, 2 dismissed, 7 discontinued, 1 rejected). In 6 cases it joined the proceedings as a participant.
Trademarks
Fresenius Kabi Polska holds 8 active trademarks registered with the Polish Patent Office. 10 marks have expired or were not registered. The first mark was filed in 1995.
| Mark | Protected until | |
|---|---|---|
| żywienie ma znaczenie | Oct 11, 2034 | |
| żywienie ma znaczenie | Sep 24, 2034 | |
| mój Fresubin | Sep 24, 2034 | |
| MOC PŁYNOTERAPII | Nov 13, 2028 | |
| ŻYCIE W PŁYNIE | Dec 14, 2027 |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, two members of the management board jointly or one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Fresenius Kabi Ag | 226,080 | $3,053,484.60 | 41.6661% |
Others | 316,520 | $4,274,986.49 | 58.3339% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
DOM Medicasp. z o.o. | 270,097.24 USD | 99.99% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Adamed PharmaS.A. | $541,927,181.76 | adamed.com.pl | ||
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $160,174,284.28 | anpharm.pl | ||
| Biofarmsp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Farmak Internationalsp. z o.o. | $101,647,142.16 | farmakinternational.pl | ||
| ICN Polfa RzeszówS.A. | $85,044,250.03 | icnpolfa.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| BiotonS.A. | $71,777,247.61 | bioton.com | ||
| Phytopharm KlękaS.A. | $46,154,888.31 | phytopharm.pl | ||
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $40,633,950.51 | biomed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2018-12-06 | Address change (Al. Aleje Jerozolimskie 134, 02-305, Warszawa → Aleje Jerozolimskie 134, 02-305, Warszawa) | |
| 2015-12-02 | Address change (Hrubieszowska 2, 01-209, Warszawa → Al. Aleje Jerozolimskie 134, 02-305, Warszawa) | |
| 2012-11-27 | Share capital change (14,130,000.00 PLN → 27,130,000.00 PLN) | |
| 2009-09-07 | Share capital change (11,304,000.00 PLN → 14,130,000.00 PLN) | |
| 2005-06-07 | Address change (Aleje Jerozolimskie 146d, 02-305, Warszawa → Hrubieszowska 2, 01-209, Warszawa) |
FAQ
Last updated: 2026-10-07